Terms: = Breast cancer AND CEACAM5, CEA
1610 results:
1. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, Prognosis, and Management in Stage I-III Colon cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
Lv J; Zhang J; Wu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation.
Li L; Xu Y; Lai Z; Li D; Sun Q; Li Z; Zhou Y
J Transl Med; 2024 Apr; 22(1):331. PubMed ID: 38575942
[TBL] [Abstract] [Full Text] [Related]
4. Cervical Epidural Anesthesia Combined with Sedation for Neck cancer Surgery: A Case Report.
Coral G; Ayala M
A A Pract; 2024 Apr; 18(4):e01775. PubMed ID: 38572891
[TBL] [Abstract] [Full Text] [Related]
5. Potential Value of HSP90α in Prognosis of Triple-Negative breast cancer.
Wang HF; Chen Y; Cao B; Pei J
Med Sci Monit; 2024 Mar; 30():e943049. PubMed ID: 38553816
[TBL] [Abstract] [Full Text] [Related]
6. [Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis].
Teranishi N; Inagaki S; Yoshida H; Nagasawa S; Takane Y; Yan M; Takahashi M; Masubuchi M; Wakabayashi K; Uetake H; Itoh Y
Gan To Kagaku Ryoho; 2024 Feb; 51(2):199-201. PubMed ID: 38449412
[TBL] [Abstract] [Full Text] [Related]
7. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
8. EFFECT OF MAMMOGRAPHY IMAGING PROCEDURE ON SERUM INFLAMMATORY AND/OR TUMOR MARKER LEVELS.
Sahingoz Erdal G; Akdogan Gemici A; Cikot M; Apikoglu Rabus S; Isiksacan N; Inci E; Hursitoglu M
Acta Clin Croat; 2023 Apr; 62(1):201-207. PubMed ID: 38304366
[TBL] [Abstract] [Full Text] [Related]
9. New ceaCAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Jancewicz I; Śmiech M; Winiarska M; Zagozdzon R; Wisniewski P
Cancer Immunol Immunother; 2024 Jan; 73(2):30. PubMed ID: 38279989
[TBL] [Abstract] [Full Text] [Related]
10. The emerging roles of ceaCAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
11. A comprehensive evaluation of circ_0065214/ miR-188-3p/GPNMB axis in breast cancer.
Wu XX; Zhao YX; Xu SL; Wang LX; Mao JH; Wang B; Yang H
Cell Signal; 2024 Mar; 115():111019. PubMed ID: 38141793
[TBL] [Abstract] [Full Text] [Related]
12. Serum human epidermal growth factor receptor-2 extracellular domain, carcinoma embryonic antigen and carbohydrate antigen 15-3 combined detection in early diagnosis of breast cancer.
Yuan Q; Song JY; Ye LQ; Zhang YM
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085516
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning-based models for the prediction of breast cancer recurrence risk.
Zuo D; Yang L; Jin Y; Qi H; Liu Y; Ren L
BMC Med Inform Decis Mak; 2023 Nov; 23(1):276. PubMed ID: 38031071
[TBL] [Abstract] [Full Text] [Related]
14. Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels.
Fathy A; Abdelrazek MA; Attallah AM; Abouzid A; El-Far M
Breast Cancer; 2024 Jan; 31(1):116-123. PubMed ID: 37973687
[TBL] [Abstract] [Full Text] [Related]
15. Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.
Chi Y; Su M; Zhou D; Zheng F; Zhang B; Qiang L; Ren G; Song L; Bu B; Fang S; Yu B; Zhou J; Yu J; Li H
Elife; 2023 Nov; 12():. PubMed ID: 37929934
[TBL] [Abstract] [Full Text] [Related]
16. FTO, PIK3CB serve as potential markers to complement cea and CA15-3 for the diagnosis of breast cancer.
Mi J; Zhang H; Cao W; Yuan C
Medicine (Baltimore); 2023 Oct; 102(42):e35361. PubMed ID: 37861518
[TBL] [Abstract] [Full Text] [Related]
17. The Leser-Trélat Sign in a Patient with Gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Efficacy of Neoadjuvant Chemotherapy plus Modified Radical Mastectomy for Stage II-III breast cancer Patients and Its Influence on Serum Tumor Markers.
Yan S; Li J; Chen J; Zhou Y; Qiu Y; Chen Y; Wu W
Altern Ther Health Med; 2024 Jan; 30(1):260-264. PubMed ID: 37773687
[TBL] [Abstract] [Full Text] [Related]
19. Ultrasound and clinicopathological characteristics of breast cancer for predicting axillary lymph node metastasis.
Bai X; Wang Y; Song R; Li S; Song Y; Wang H; Tong X; Wei W; Ruan L; Zhao Q
Clin Hemorheol Microcirc; 2023; 85(2):147-162. PubMed ID: 37694357
[TBL] [Abstract] [Full Text] [Related]
20. Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer.
Su Q; Wang X; Zhu R; Liu C; Sun S
Sci Rep; 2023 Sep; 13(1):14791. PubMed ID: 37684327
[TBL] [Abstract] [Full Text] [Related]
[Next]
